Heska reports income drop in Q1
The Loveland-based company brought in $19.2 million in revenue in the first quarter, down from $19.5 million in the same period of 2011. The majority of Heska's revenue came from its core companion animal health division, which brought in $16.6 million, up from $16.4 million in the first quarter of 2011.
"We grew our core companion animal health revenue despite an anticipated $2.1 million decline in revenue from our heatworm preventive, (which was) sold to a unit of Merck," said Robert Grieve, chairman and CEO.
The company saw an increase in operating expenses, from $3.9 million in the first quarter of 2011 to $4.8 million in the same period of 2012.
More breaking news...
Synergy increases borrowing base to $90M
Neuromuscular science program seeks funds
"It gives us another $15 million on the credit facility
The Muscles Alive! program
Columbine Health's Windsor facility complete
Polis, COGA spar over fracking votes
Nursing shortage? Not in Colorado…yet